Ebenezer O. Sackey

Array ( [id] => 5972616 [patent_doc_number] => 20110152235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Aminopyrimidine Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/978089 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 55659 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152235.pdf [firstpage_image] =>[orig_patent_app_number] => 12978089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9850272 [patent_doc_number] => 08952001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Amino-heteroaryl derivatives as HCN blockers' [patent_app_type] => utility [patent_app_number] => 13/518427 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13391 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995930 [patent_doc_number] => 09040529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => '4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity' [patent_app_type] => utility [patent_app_number] => 13/517120 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23688 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972906 [patent_doc_number] => 20110152300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => '2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/970437 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12827 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152300.pdf [firstpage_image] =>[orig_patent_app_number] => 12970437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972923 [patent_doc_number] => 20110152303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Chemical Compounds' [patent_app_type] => utility [patent_app_number] => 12/970366 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9655 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152303.pdf [firstpage_image] =>[orig_patent_app_number] => 12970366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9971166 [patent_doc_number] => 09018175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => '3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives' [patent_app_type] => utility [patent_app_number] => 13/515214 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61689 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063505 [patent_doc_number] => 20110245269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Inhibitors of Advanced Glycation End Products' [patent_app_type] => utility [patent_app_number] => 12/964322 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15258 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245269.pdf [firstpage_image] =>[orig_patent_app_number] => 12964322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417681 [patent_doc_number] => 20120245182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1--1-METHYL-UREA AND SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/514308 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11726 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214846 [patent_doc_number] => 20110137033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'PROCESS FOR PREPARING (4,6-DIMETHYLPYRIMIDIN-2-YL)PHENYLAMINE (PYRIMETHANIL)' [patent_app_type] => utility [patent_app_number] => 12/959476 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1482 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137033.pdf [firstpage_image] =>[orig_patent_app_number] => 12959476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577747 [patent_doc_number] => 08343957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Therapeutic pyrazoloquinoline urea derivatives' [patent_app_type] => utility [patent_app_number] => 12/955792 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17948 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12955792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465712 [patent_doc_number] => 20120270880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'PYRROLO [2,3-D] PYRAZIN-7-YLPYRIMIDINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/518419 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16535 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039465 [patent_doc_number] => 20110092514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'COMPOUNDS WITH ANTI-CANCER ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/950297 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40558 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092514.pdf [firstpage_image] =>[orig_patent_app_number] => 12950297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9232855 [patent_doc_number] => 08598159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Therapeutic pyrazoloquinoline derivatives' [patent_app_type] => utility [patent_app_number] => 12/949655 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23967 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12949655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8944083 [patent_doc_number] => 08497262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Therapeutic pyrazolonaphthyridine derivatives' [patent_app_type] => utility [patent_app_number] => 12/949619 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11926 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12949619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496437 [patent_doc_number] => 20120295845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'IMIDAZO-PYRAZOLES AS GPR119 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/510129 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22902 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587331 [patent_doc_number] => 20110281841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/945629 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28417 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281841.pdf [firstpage_image] =>[orig_patent_app_number] => 12945629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054601 [patent_doc_number] => 20110110961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'PROLYL HYDROXYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/940891 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 36046 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110961.pdf [firstpage_image] =>[orig_patent_app_number] => 12940891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026045 [patent_doc_number] => 20110053917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Allosteric Modulators of the A1 Adenosine Receptor' [patent_app_type] => utility [patent_app_number] => 12/939601 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27672 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053917.pdf [firstpage_image] =>[orig_patent_app_number] => 12939601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516763 [patent_doc_number] => 20120316171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/505895 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49706 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11450274 [patent_doc_number] => 09573907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-21 [patent_title] => '2, 4-pyrimidine derivatives and use thereof' [patent_app_type] => utility [patent_app_number] => 13/505651 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20546 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505651 [rel_patent_id] =>[rel_patent_doc_number] =>)